2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC984
Submitter : Mr. Lenny Marano Date & Time: 10/27/2005 09:10:55
Organization : Mr. Lenny Marano
Category : Individual Consumer
Issue Areas/Comments
I am writing to express my oppositon to any delay that would prevent women and women who are victims of sexual assualt from havig immediate and unfettered access to emergency contraception. I therefore urge the FDA to again follow the recommendations of the FDA's advisory panel that EC be available without any restrictions.